FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes

Journal of the American College of Cardiology

Volumn 63, Issue 10, 2014, Pages 1011-1019

  Pfister, Otmar ^a   Lorenz, Vera ^a   Oikonomopoulos, Angelos ^b   Xu, Lifen ^a   Häuselmann, Stéphanie P ^a   Mbah, Christopher ^b   Kaufmann, Beat A ^a   Liao, Ronglih ^b   Wodnar Filipowicz, Aleksandra ^a   Kuster, Gabriela M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

apoptosis; heart failure; hematopoietic cytokines; myocardial infarction; receptor tyrosine kinase; remodeling

Indexed keywords

CD135 ANTIGEN; FLT3 LIGAND; MESSENGER RNA; PROTEIN BCL 2; PROTEIN KINASE B; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG TARGETING; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; INTRAMYOCARDIAL DRUG ADMINISTRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; POST MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; UPREGULATION; HEART FUNCTION; HISTOPATHOLOGY; IN VITRO STUDY;

APOPTOSIS; HEART FAILURE; HEMATOPOIETIC CYTOKINES; MYOCARDIAL INFARCTION; RECEPTOR TYROSINE KINASE; REMODELING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; APOPTOSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRALESIONAL; LIGANDS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR REMODELING;

EID: 84896102327     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.1647     Document Type: Article

References (39)

1. A. Wodnar-Filipowicz Flt3 ligand: role in control of hematopoietic and immune functions of the bone marrow News Physiol Sci 18 2003 247 251
2. D.G. Gilliland, and J.D. Griffin The roles of FLT3 in hematopoiesis and leukemia Blood 100 2002 1532 1542
3. S.D. Lyman, L. James, and T. Vanden Bos et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells Cell 75 1993 1157 1167
4. O.P. Veiby, F.W. Jacobsen, L. Cui, S.D. Lyman, and S.E. Jacobsen The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta J Immunol 157 1996 2953 2960
5. O. deLapeyriere, P. Naquet, and J. Planche et al. Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues Differentiation 58 1995 351 359
6. C. Hannum, J. Culpepper, and D. Campbell et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs Nature 368 1994 643 648
7. S.D. Lyman, L. James, and L. Johnson et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells Blood 83 1994 2795 2801
8. B.B. Ayach, M. Yoshimitsu, and F. Dawood et al. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction Proc Natl Acad Sci U S A 103 2006 2304 2309
9. A.M. Leone, S. Rutella, and G. Bonanno et al. Endogenous G-CSF and CD34(+) cell mobilization after acute myocardial infarction Int J Cardiol 111 2006 202 208
10. S. Namiuchi, Y. Kagaya, and J. Ohta et al. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention J Am Coll Cardiol 45 2005 1406 1412
11. M. Harada, Y. Qin, and H. Takano et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes Nat Med 11 2005 305 311
12. G.L. Wright, P. Hanlon, K. Amin, C. Steenbergen, E. Murphy, and M.O. Arcasoy Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB J 18 2004 1031 1033
13. F. Bussolino, J.M. Wang, and P. Defilippi et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate Nature 337 1989 471 473
14. A. Anagnostou, E.S. Lee, N. Kessimian, R. Levinson, and M. Steiner Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells Proc Natl Acad Sci U S A 87 1990 5978 5982
15. A.P. Beltrami, L. Barlucchi, and D. Torella et al. Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
16. R. Swords, C. Freeman, and F. Giles Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia Leukemia 26 2012 2176 2185
17. T.F. Chu, M.A. Rupnick, and R. Kerkela et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib Lancet 370 2007 2011 2019
18. R. Kerkela, L. Grazette, and R. Yacobi et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate Nat Med 12 2006 908 916
19. R. Kerkela, K.C. Woulfe, and J.B. Durand et al. Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase Clin Transl Sci 2 2009 15 25
20. H. Lal, K.L. Kolaja, and T. Force Cancer genetics and the cardiotoxicity of the therapeutics J Am Coll Cardiol 61 2013 267 274
21. C.M. Thaik, A. Calderone, N. Takahashi, and W.S. Colucci Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes J Clin Invest 96 1995 1093 1099
22. F. Mouquet, O. Pfister, and M. Jain et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells Circ Res 97 2005 1090 1092
23. S.G. Kennedy, E.S. Kandel, T.K. Cross, and N. Hay Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria Mol Cell Biol 19 1999 5800 5810
24. H. Dudek, S.R. Datta, and T.F. Franke et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661 665
25. Q. Xu, S.E. Simpson, T.J. Scialla, A. Bagg, and M. Carroll Survival of acute myeloid leukemia cells requires PI3 kinase activation Blood 102 2003 972 980
26. C.H. Brandts, B. Sargin, and M. Rode et al. Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation Cancer Res 65 2005 9643 9650
27. Z.N. Oltvai, C.L. Milliman, and S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609 619
28. M. Lisovsky, Z. Estrov, and X. Zhang et al. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax Blood 88 1996 3987 3997
29. D. Orlic, J. Kajstura, and S. Chimenti et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci U S A 98 2001 10344 10349
30. H. Kawada, J. Fujita, and K. Kinjo et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction Blood 104 2004 3581 3587
31. B. Dawn, Y. Guo, and A. Rezazadeh et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function Circ Res 98 2006 1098 1105
32. T. Force, D.S. Krause, and R.A. Van Etten Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition Nat Rev Cancer 7 2007 332 344
33. A.Y. Khakoo, C.M. Kassiotis, and N. Tannir et al. Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor Cancer 112 2008 2500 2508
34. M. Schmidinger, C.C. Zielinski, and U.M. Vogl et al. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma J Clin Oncol 26 2008 5204 5212
35. M.H. Chen, R. Kerkela, and T. Force Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics Circulation 118 2008 84 95
36. D. May, D. Gilon, and V. Djonov et al. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation Proc Natl Acad Sci U S A 105 2008 282 287
37. V. Chintalgattu, D. Ai, and R.R. Langley et al. Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress J Clin Invest 120 2010 472 484
38. E. Maraskovsky, E. Daro, and E. Roux et al. In vivo generation of human dendritic cell subsets by Flt3 ligand Blood 96 2000 878 884
39. C.S. Higano, N.J. Vogelzang, J.A. Sosman, A. Feng, D. Caron, and E.J. Small Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer Clin Cancer Res 10 2004 1219 1225